Loading...
Terex Corp (TEX) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has strong positive catalysts, including bullish technical indicators, significant hedge fund buying, and favorable analyst ratings with upward price target revisions. Despite a recent dip in price, the long-term growth potential, merger synergies, and solid financial performance make it a compelling investment opportunity.
The MACD is positive and expanding, indicating bullish momentum. The RSI is neutral at 59.189, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 57.249, and resistance is at 69.191, suggesting room for upward movement. The stock has a 70% chance to gain 4.97% over the next month.

Hedge funds are significantly increasing their positions in the stock (1812.79% increase in buying).
Analysts have raised price targets significantly, with Baird setting a target of $100 and Truist at $
The company reported strong Q4 sales growth (8%) and a 32% increase in bookings.
Merger with REV Group is expected to generate synergies and improve financial performance.
Stable dividend payout of $0.17 per share reflects commitment to shareholder returns.
Recent market price decline (-2.59% in regular market and -1.42% in pre-market).
Net income and EPS have significantly dropped YoY in Q4 2025, raising concerns about profitability.
In Q4 2025, revenue increased by 6.20% YoY to $1.318 billion, and gross margin improved by 18.59% YoY to 18.82%. However, net income dropped to $63 million (-3250.00% YoY), and EPS fell to $0.95 (-3266.67% YoY). The company is focusing on divesting non-core businesses to stabilize revenue sources.
Analysts are bullish overall, with multiple firms raising price targets following Q4 results. Baird raised its target to $100 and designated the stock as a 'Fresh Pick,' while Truist increased its target to $82, citing strong bookings and portfolio visibility. Citi maintained a Neutral rating but raised its target to $73. Morgan Stanley upgraded the stock to Overweight with a $60 target, citing improved valuation and portfolio.